Drug resistance in pituitary tumours: from cell membrane to intracellular signalling
Drug resistance in pituitary tumours: from cell membrane to intracellular signalling
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The pharmacological treatment of pituitary tumours is based on the use of stable analogues of somatostatin and dopamine. The analogues bind to somatostatin receptor types 2 and 5 (SST2 and SST5) and dopamine receptor type 2 (DRD2), respectively, and generate signal transduction cascades in cancerous pituitary cells that culminate in the inhibition...
Alternative Titles
Full title
Drug resistance in pituitary tumours: from cell membrane to intracellular signalling
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2547532716
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2547532716
Other Identifiers
ISSN
1759-5029
E-ISSN
1759-5037
DOI
10.1038/s41574-021-00514-0
